Dark Mode Light Mode

Happydemics raises €13 million to redefine the standards of advertising effectiveness measurement.

Happydemics aims to reshape the standards of advertising effectiveness measurement by leveraging artificial intelligence. The Paris-based scale-up offers a unified measurement technology that spans a wide range of media channels—OOH, DOOH, CTV, audio, in-game, display—enabling advertisers to gain a comprehensive and harmonized view of their campaign performances.

With a database containing over 25,000 criteria across media types, geographic areas, and industries, Happydemics provides advertisers with precise insights to optimize their investments. The integration of AI into its tools enhances result prediction and enables continuous campaign optimization, addressing growing demands for scalability and transparency.

In a global advertising market valued at over $1 trillion, where a significant portion of investments still lacks reliable measurement, Happydemics aims to establish a universal standard for advertising performance. The company relies on its Brand Lift technology to meet these challenges while ensuring cross-channel and cross-region comparability.

To support this vision, Happydemics raised €13 million in a Series B round led by Wille Finance and Adelie Capital. These funds will enable the company to accelerate its international expansion, particularly in Europe and the United States, and continue investing in the development of AI-driven solutions. With a 107% revenue growth in 2023 and over 2,000 advertisers served across 60 countries, Happydemics positions itself as a key player in adtech.

Previous Post

PATHWAY raises €9.4M to expand its real-time AI in the United States

Next Post

ORAKL ONCOLOGY raises €11 million to develop tumor avatars.

Advertisement